Clinical Trials
2 trialsNCT06932757 2025-06-03
Adjuvant Quisinostat in High-Risk Uveal Melanoma
University of Miami
Phase 2 Recruiting
NCT01486277 2016-11-03
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma
Janssen Research & Development, LLC
Phase 2 Completed